Pain News and Research

Latest Pain News and Research

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd Medical AB with collaborators has received a three million dollar grant from the US National Institutes of Health to develop the Company's patented Nerve Targeting Drug Delivery System (NTDDS) for prevention of Chemotherapy Induced Peripheral Neuropathy.

12 Sep 2011

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Nektar Therapeutics announced today that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California.

12 Sep 2011

Preterm babies may be experiencing pain during procedures: Study

Preterm may begin to feel pain around a woman's 35th week of pregnancy, about two to four weeks before delivery, according to a new study from University College London. Using EEG, researchers recorded the babies' brain activity in response to pain, comparing their pain responses from a touch and prick on the heels. The findings were published in the journal Current Biology.

9 Sep 2011

Research roundup: U.S. doctors' pay exceeds foreign counterparts; Medicare Advantage prevents some hospitalizations

Higher Fees Paid To US Physicians Drive Higher Spending For Physician Services Compared To Other Countries -- Researchers focused on primary care visits and hip replacements in the U.S., Britain, Australia, Canada, France and Germany and found that, "public and private payers paid somewhat higher fees to US primary care physicians.

9 Sep 2011

Zimmer supports GEANCO's orthopaedic mission to Nigeria

The GEANCO Foundation, a not-for-profit organization dedicated to improving healthcare delivery for the people of Nigeria, is organizing a medical mission for two surgeons and fifteen support team members to travel to the West African country to provide orthopaedic treatment to patients suffering from disabling joint diseases.

9 Sep 2011

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

9 Sep 2011

SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010

The use of illicit drugs among Americans increased between 2008 and 2010 according to a national survey conducted by the Substance Abuse and Mental Health Services Administration.

9 Sep 2011

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Sagene Pharmaceuticals, Inc., a biopharmaceutical company focused on developing combinations of FDA-approved drugs to treat diseases associated with aging, has completed a pre-IND meeting with the Division of Reproductive and Urologic Products of the FDA to discuss the development plan for SPI-1972, a dual-action combination treatment for erectile dysfunction.

9 Sep 2011

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

9 Sep 2011

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

A new report reveals that survival rates in the UK for people with pancreatic cancer are among the worst in the world. The report recommends earlier diagnosis and better treatment.

8 Sep 2011

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent -- or 35.4 million -- do so every day.

8 Sep 2011

Cam impingement may increase risk of hip OA in young men

Hip impingement may be a risk factor of osteoarthritis (OA) of the hip. A new study reveals that the presence of an underlying deformity, known as cam impingement, is associated with hip damage in young men without any arthritis symptoms and detected using magnetic resonance imaging.

8 Sep 2011

Medical students may act on unconscious racial preferences

New Johns Hopkins research shows that medical students — just like the general American population — may have unconscious if not overt preferences for white people, but this innate bias does not appear to translate into different or lesser health care of other races.

8 Sep 2011

Inhibition of Sab protein protects liver from acetaminophen toxicity

New research from the Keck School of Medicine of the University of Southern California (USC) may help prevent damage to the liver caused by drugs like acetaminophen and other stressors.

8 Sep 2011

Exercise, intervention may help individuals with peripheral arterial disease

Peripheral arterial disease, or PAD, is a common condition affecting 12-20 percent of Americans age 65 and older that may be a signal of future heart attack and stroke-and many with the disease may be unaware they have it, says the Society of Interventional Radiology.

8 Sep 2011

Simple pain relievers a better alternative to antipsychotic medications for dementia patients

Many dementia patients are being treated with antipsychotic medications, but a new study shows that simple pain relievers may be a better alternative.

8 Sep 2011

First-ever comprehensive study of species origins of nature-derived drugs

In a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting the conventional view that as every nature species produces biologically active molecules, one can find drugs from almost any major block of species groups if one looks for them hard enough.

8 Sep 2011

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

AOI Medical, Inc. has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Ascendx Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF).

8 Sep 2011

Experts to address crucial issues of pain management and disability health reform

Leading Australian and international medical experts will convene in Brisbane next week to address crucial areas of rehabilitation medicine, including health reform, barriers to rehabilitation healthcare services and pain management.

7 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

Pain News and Research

Latest Pain News and Research

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Preterm babies may be experiencing pain during procedures: Study

Research roundup: U.S. doctors' pay exceeds foreign counterparts; Medicare Advantage prevents some hospitalizations

Zimmer supports GEANCO's orthopaedic mission to Nigeria

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Pancreatic cancer outcomes poor in UK – experts urge better diagnosis and treatment

CDC reports slight drop in smoking; tick worries blood experts

Cam impingement may increase risk of hip OA in young men

Medical students may act on unconscious racial preferences

Inhibition of Sab protein protects liver from acetaminophen toxicity

Exercise, intervention may help individuals with peripheral arterial disease

Simple pain relievers a better alternative to antipsychotic medications for dementia patients

First-ever comprehensive study of species origins of nature-derived drugs

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

Experts to address crucial issues of pain management and disability health reform

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pain News and Research

Latest Pain News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in